BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24960118)

  • 1. Multivalent viral capsids with internal cargo for fibrin imaging.
    Obermeyer AC; Capehart SL; Jarman JB; Francis MB
    PLoS One; 2014; 9(6):e100678. PubMed ID: 24960118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-surface modified virus capsids for targeted delivery of photodynamic agents to cancer cells.
    Stephanopoulos N; Tong GJ; Hsiao SC; Francis MB
    ACS Nano; 2010 Oct; 4(10):6014-20. PubMed ID: 20863095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particles.
    Ashley CE; Carnes EC; Phillips GK; Durfee PN; Buley MD; Lino CA; Padilla DP; Phillips B; Carter MB; Willman CL; Brinker CJ; Caldeira Jdo C; Chackerian B; Wharton W; Peabody DS
    ACS Nano; 2011 Jul; 5(7):5729-45. PubMed ID: 21615170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodistribution of Antibody-MS2 Viral Capsid Conjugates in Breast Cancer Models.
    Aanei IL; ElSohly AM; Farkas ME; Netirojjanakul C; Regan M; Taylor Murphy S; O'Neil JP; Seo Y; Francis MB
    Mol Pharm; 2016 Nov; 13(11):3764-3772. PubMed ID: 27611245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET Imaging and biodistribution of chemically modified bacteriophage MS2.
    Farkas ME; Aanei IL; Behrens CR; Tong GJ; Murphy ST; O'Neil JP; Francis MB
    Mol Pharm; 2013 Jan; 10(1):69-76. PubMed ID: 23214968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-surface-modified bacteriophage MS2 as an ideal scaffold for a viral capsid-based drug delivery system.
    Kovacs EW; Hooker JM; Romanini DW; Holder PG; Berry KE; Francis MB
    Bioconjug Chem; 2007; 18(4):1140-7. PubMed ID: 17602681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular imaging of fibrin deposition in deep vein thrombosis using fibrin-targeted near-infrared fluorescence.
    Hara T; Bhayana B; Thompson B; Kessinger CW; Khatri A; McCarthy JR; Weissleder R; Lin CP; Tearney GJ; Jaffer FA
    JACC Cardiovasc Imaging; 2012 Jun; 5(6):607-15. PubMed ID: 22698530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance contrast agents from viral capsid shells: a comparison of exterior and interior cargo strategies.
    Hooker JM; Datta A; Botta M; Raymond KN; Francis MB
    Nano Lett; 2007 Aug; 7(8):2207-10. PubMed ID: 17630809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High relaxivity gadolinium hydroxypyridonate-viral capsid conjugates: nanosized MRI contrast agents.
    Datta A; Hooker JM; Botta M; Francis MB; Aime S; Raymond KN
    J Am Chem Soc; 2008 Feb; 130(8):2546-52. PubMed ID: 18247608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal nanoagents for the detection of intravascular thrombi.
    McCarthy JR; Patel P; Botnaru I; Haghayeghi P; Weissleder R; Jaffer FA
    Bioconjug Chem; 2009 Jun; 20(6):1251-5. PubMed ID: 19456115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of amino acid substitution on the thermal stability of MS2 capsids lacking genomic RNA.
    Stonehouse NJ; Stockley PG
    FEBS Lett; 1993 Nov; 334(3):355-9. PubMed ID: 8243647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-free viral capsids as carriers for positron emission tomography radiolabels.
    Hooker JM; O'Neil JP; Romanini DW; Taylor SE; Francis MB
    Mol Imaging Biol; 2008; 10(4):182-91. PubMed ID: 18437498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriophage MS2 displays unreported capsid variability assembling T = 4 and mixed capsids.
    de Martín Garrido N; Crone MA; Ramlaul K; Simpson PA; Freemont PS; Aylett CHS
    Mol Microbiol; 2020 Jan; 113(1):143-152. PubMed ID: 31618483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide-based fibrin-targeting probes for thrombus imaging.
    Oliveira BL; Caravan P
    Dalton Trans; 2017 Oct; 46(42):14488-14508. PubMed ID: 29051933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct Imaging of Cerebral Thromboemboli Using Computed Tomography and Fibrin-targeted Gold Nanoparticles.
    Kim JY; Ryu JH; Schellingerhout D; Sun IC; Lee SK; Jeon S; Kim J; Kwon IC; Nahrendorf M; Ahn CH; Kim K; Kim DE
    Theranostics; 2015; 5(10):1098-114. PubMed ID: 26199648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encapsulation of Negatively Charged Cargo in MS2 Viral Capsids.
    Aanei IL; Glasgow JE; Capehart SL; Francis MB
    Methods Mol Biol; 2018; 1776():303-317. PubMed ID: 29869251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Biological Evaluation of Cyclic [
    Rezaeianpour S; Bozorgi AH; Moghimi A; Almasi A; Balalaie S; Ramezanpour S; Nasoohi S; Mazidi SM; Geramifar P; Bitarafan-Rajabi A; Shahhosseini S
    Mol Imaging Biol; 2017 Apr; 19(2):256-264. PubMed ID: 27632423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPECT imaging of fibrin using fibrin-binding peptides.
    Starmans LW; van Duijnhoven SM; Rossin R; Aime S; Daemen MJ; Nicolay K; Grüll H
    Contrast Media Mol Imaging; 2013; 8(3):229-37. PubMed ID: 23606426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual Surface Modification of Genome-Free MS2 Capsids for Delivery Applications.
    Aanei IL; Francis MB
    Methods Mol Biol; 2018; 1776():629-642. PubMed ID: 29869270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Red clover necrotic mosaic virus capsid as a multifunctional cell targeting plant viral nanoparticle.
    Lockney DM; Guenther RN; Loo L; Overton W; Antonelli R; Clark J; Hu M; Luft C; Lommel SA; Franzen S
    Bioconjug Chem; 2011 Jan; 22(1):67-73. PubMed ID: 21126069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.